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Evidence from a number of 
fields indicates that phenotypic 
variation among individuals and 
among somatic cells increases 
with age [1–5]. However, no 
evidence for an age-dependent 
increase in variation in gene 
expression has yet been found 
[6–9]. Using eight microarray 
data sets from different studies 
in humans and rats, we find that 
gene expression becomes more 
variable with advancing age. This 
age-correlated heterogeneity 
of expression (ACHE) has a 
minor effect on individual genes, 
but is widespread throughout 
the transcriptome. We find no 
evidence for ACHE being caused 
by germline mutations or by 
differences in aging rates between 
individuals. However, our results 
are compatible with ACHE being 
an outcome of the accumulation 
of stochastic effects at the cellular 
level. 
We designed a statistical 
test that measures an increase 
in expression heterogeneity 
with age. ACHE is calculated 
separately for each probe 
set (a probe set detects one 
mRNA transcript in microarray 
experiments). We tested eight 
microarray data sets, including 
data from human kidney 
(cortex and medulla), human 
skeletal muscle, post-mortem 
human cerebral cortex and 
rat hippocampus, for an 
excess of probe sets showing 
ACHE (Figure 1). The random 
expectation was calculated 
through permutations 
(see Supplemental Data 
published with this article  
online). 
We found that the proportion 
of probe sets showing a positive 
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Figure 1. Data sets and results of the Age-Correlated Heterogeneity of Expression 
(ACHE) test. 
(A) Age distribution of subjects in the data sets. Human ages are given in years, rat ages 
in months. In parentheses, the number of subjects is given as ‘N’, the number of probe 
sets used in quantitative ACHE analyses is given as ‘n’. The ACHE test for increase in 
heterogeneity with age is conducted on each probe set independently and makes use 
of regression models between expression level and age [14] (Supplemental Data). (B) 
An example from the human brain data set B, the log-expression versus age plot for a 
probe set detecting the gene PIM-1, for which the ACHE test p-value was calculated as 
0.0002. (C) ACHE test p-value distribution for human brain B. (D) shows the main result 
of the study for quantitative gene expression. The heights of the bars indicate observed 
to expected ratios of the number of probe sets at different cutoffs within the ACHE test 
p-value distribution. The observed number is the number of probe sets found within 
the regions of the p-value distributions at cutoffs p ≤ 0.05, p ≥ 0.95 and p < 0.5, from 
top to bottom. The expected number is the median number of probe sets found within 
1000 random p-value distributions at the same cutoff, which represents the expecta-
tion under the null hypothesis. The dashed line shows observed to expected ratio = 1. 
Significance of the observed to expected ratios are indicated above the bars as (o) for 
0.05 < p ≤ 0.10, as (*) for 0.01 < p ≤ 0.05, as (**) for 0.001 < p ≤ 0.01 and as (***) for p ≤ 
0.001. None of the results are significant in the direction of increase in homogeneity 
with age. expression variation (at ACHE  
test p ≤ 0.05) was more than 
expected in seven of the eight 
data sets (Figure 1D). In four 
of these data sets, the excess 
was significant (permutation 
test p ≤ 0.01), resulting in 
an overall significance of 
p = 7×10-7 (Binomial test)  
across all eight data sets. 
Similarly, the proportion of  probe sets showing an increase  
in expression homogeneity at  
p ≥ 0.95 was less than expected  
in seven of the eight  
experiments.
Additionally, we tested for 
heterogeneity in gene expression 
at the qualitative level (i.e. whether 
a gene is expressed or not). The 
proportion of probe sets showing 
a positive correlation between 
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variation at p ≤ 0.05 was more 
than expected in seven of the 
eight data sets and three of these 
were significant (permutation test 
p ≤ 0.05), resulting in an overall 
significance of p = 0.006 (Binomial 
test). The results from both the 
quantitative and the qualitative 
dimensions of gene expression 
indicate that ACHE is a weak but 
pervasive characteristic of the 
human and rat transcriptomes.
What might be causing ACHE? 
We first asked whether genes 
showing strong ACHE at  
p ≤ 0.05 differ in a consistent 
way from other genes. We 
found that, first, there was no 
significant overlap between genes 
showing strong ACHE in different 
experiments. Second, there was 
no significant enrichment of 
strong ACHE genes in functional 
gene groups. Lastly, we observed 
a correlation between decrease 
in expression levels and increase 
in variation. However, ACHE 
was not restricted to genes 
undergoing age-related- decrease 
in expression levels  
(Supplemental Data). Taken 
together, these results imply that 
genes showing strong ACHE do 
not belong to a specific set of 
genes.
Medawar's germline mutation 
accumulation theory of aging [3] 
provides a possible explanation 
for ACHE. Because old individuals 
contribute less to the next 
generation than the young,  
the force of purifying selection 
on the old phenotype is weaker. 
Therefore, a deleterious germline 
mutation that affects gene 
expression only at old age will 
have a higher probability of 
remaining within the population 
than other mutations. What we 
are observing as ACHE could 
therefore be a signature of 
this old-age-specific genetic 
heterogeneity. However, a 
genetically homogenous rat 
population also displayed 
significant ACHE (Figure 1D). 
Thus, the germline mutation 
accumulation theory cannot fully 
account for the ACHE effect.
Another possible source of 
ACHE are differences in aging 
rates between individuals [10]. 
If expression profiles are similar among young individuals, but  
then change at different rates 
due to genetic or environmental 
variation, the expression profiles 
of the old will be relatively 
heterogeneous. To evaluate 
this hypothesis, we assigned 
an ‘expression age’ to each 
individual for each gene, 
according to expression level [11] 
(Supplemental Data). Expression 
ages derived from independent 
sets of genes were tightly 
correlated, implying that, within 
an individual, the vast majority of 
genes change their expression 
levels with age at similar rates. 
However, we did not detect a 
significant age-related increase 
in the absolute differences 
between mean expression ages 
and chronological ages, which 
we would expect if differences in 
aging rates were reflected in gene 
expression.
Our results indicate that  
ACHE is a general — but 
weak — effect in the 
transcriptome.  
This is compatible with 
ACHE being the outcome of 
accumulating stochastic effects 
in the soma, such as cellular 
damage and mutations. These 
effects will influence each cell 
in a unique way [2] so that 
expression variation among aging 
cells will be equalized at the 
tissue level. If somatic mutations 
mostly cause decreases in 
expression level [12], the overlap 
between ACHE and age- related 
decrease in expression levels 
can also be explained within this 
framework. ACHE supports the 
stochastic nature attributed to 
the aging process [10]. It implies 
a weakening of expression 
regulation with age, contrary 
to previous observations 
and hypotheses based on 
measurements on a small number 
of genes [6,13]. The extent of 
ACHE among single cells and the 
role of ACHE in aging remains to 
be determined.
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